认知干预对肝癌介入患者焦虑和抑郁情绪的影响

目的:探讨认知干预对肝癌介入患者焦虑和抑郁情绪的影响。方法:选取我院2013年01月-2014年06月于中心导管室行肝癌介入术患者86例,按随机数字表法分为对照组和实验组。对照组实施常规护理;干预组在常见护理基础上实施认知干预行为。采用焦虑自测评量表(SAS)、抑郁自量评量表(SDS)对两组患者于入院时、术前1天及术后1天和1周时进行焦虑状和抑郁态评估。结果:两组患者入院时SAS和SDS评分比较无显著性差异(t=0.24、-0.08,P0.05),与国内常模相比有明显差异(t=16.63、15.87、9.64、11.31,P0.05);与入院时比较,两组患者术前、术后1天和术后1周SAS和SDS评分明显下降(F=10.37、42.07、4.76、29.68,P0.05);与对照组同时段比较,认知干预后SAS和SDS评分相比均有明显降低(t=1.97、4.58、5.29、1.83、3.85、5.20,P0.05)。结论:积极有效的认知干预行为对肝癌介入患者的焦虑、抑郁情绪障碍具有明显的缓解和减轻作用。

Effect of Cognitive Intervention on the Anxiety and Depression in Patients with Hepatocellular Carcinoma Receiving Interventional Therapy

Objective:To explore the effect of cognitive intervention behavior on the anxiety and depression in patients with hepatocellular carcinoma.Methods:Eighty-six cases of patients with hepatocellular carcinoma, from January 2013 to June 2014, admitted in our hospital were randomly divided into the control group and the experimental group. Conventional nursing were given to both groups, besides, cognitive intervention behavior were given to the experimental group. SAS (Self-rating anxiety scale) and SDS (Self-rating depression scale) were used to evaluate the psychological condition of the patients at admission, one day before operation, one day and one week after operation.Results:There was no significant difference between the two groups in SAS and SDS scores at admission (t=0.24, -0.08, respectively, P>0.05). However, SAS and SDS scores at admission were obviously higher than average domestic level (t=16.63, 15.87, 9.64, 11.31, respectively, P<0.05). Compared with on admission, SAS and SDS scores of two groups were significantly decreased in preoperative 1 day and postoperative 1day, 1 week. (F=10.37, 42.07, 4.76, 29.68, respectively, P<0.05). Compared with the group at the same time period, SAS and SDS scores in the experimental group were significantly lower (t=1.97, 4.58, 5.29, 1.83, 3.85, 5.20, respectively, P<0.05).Conclusion:Positive and effective cognitive intervention behavior can obviously reduce the mood disorders in anxiety and depression for patients of hepatocellular carcinoma.